Scott Baylard
Optometrist · Cumming, GANPI 1255472916
Payments from drug & device makers
Across 87 payments — averaging $22.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Vision Care, Inc.$321
- Sun Pharmaceutical Industries Inc.$306
- AbbVie$235
- Alcon$222
- Notal Vision, Inc.$192
- Bausch & Lomb Americas Inc.$146
- plus $576 from 13 others
What the payments were for
- Speaking & faculty fees$19210%
- Food & beverage$1,78589%
- Entertainment$221%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Vision Care, Inc. | 12 | $321 |
| Sun Pharmaceutical Industries Inc. | 11 | $306 |
| AbbVie(2 entities) | 13 | $235 |
| Alcon | 10 | $222 |
| Notal Vision, Inc. | 1 | $192 |
| Bausch & Lomb Americas Inc. | 7 | $146 |
| Novartis | 6 | $127 |
| Oyster Point Pharma, Inc. | 6 | $114 |
| Biotissue Holdings Inc. | 5 | $75 |
| Kala Pharmaceuticals, Inc. | 3 | $55 |
| Coopervision Inc. | 3 | $50 |
| Visioneering Technologies, Inc. | 2 | $26 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $26 |
| Optos, Inc. | 1 | $22 |
| Glaukos Corporation | 1 | $19 |
| Sight Sciences, Inc. | 1 | $19 |
| Dompe US, Inc. | 1 | $19 |
| LKC Technologies, Inc. | 1 | $14 |
| Tearlab Corp | 1 | $11 |
How this compares
$1,998 in reported general payments places this provider in the 70th percentile of 1,285 optometrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Latanoprost | 19 | $108 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $85 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Cumming
- Michael HungCumming$1.2M
- Anne BrobstDuluth$1.2M
- Joshua JohnstonAtlanta$997K
- John WomackCanton$931K
- David WinnerRoswell$877K
- Lauren HackerGreensboro$511K
- Katherine WooAtlanta$336K
- Naheed AhmadRoswell$296K
- Stephanie RossAtlanta$283K
- Scott MoscowRoswell$278K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.